Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:05:10 UTC
Update Date2021-09-26 23:17:03 UTC
HMDB IDHMDB0259491
Secondary Accession NumbersNone
Metabolite Identification
Common NameN-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide
DescriptionCPG-52852 belongs to the class of organic compounds known as imidazoquinolines. These are aromatic heterocyclic compounds containing an imidazole ring fused to a quinoline ring system. In some configurations, the imidazole ring shares a nitrogen atom with the quinoline moiety. Based on a literature review very few articles have been published on CPG-52852. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-(4-(4-amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-(4-(4-amino-2-Ethyl-1H-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamideMeSH
Toll-like receptor 7 agonist 852aMeSH
N-(4-(4-amino-2-Ethyl-1H-imidazo(4,5C)quinolin-1-yl)butyl)methanesulfonamideMeSH
852a CompoundMeSH
Chemical FormulaC17H23N5O2S
Average Molecular Weight361.46
Monoisotopic Molecular Weight361.157246175
IUPAC NameN-(4-{4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl}butyl)methanesulfonamide
Traditional NameN-(4-{4-amino-2-ethylimidazo[4,5-c]quinolin-1-yl}butyl)methanesulfonamide
CAS Registry NumberNot Available
SMILES
CCC1=NC2=C(N1CCCCNS(C)(=O)=O)C1=CC=CC=C1N=C2N
InChI Identifier
InChI=1S/C17H23N5O2S/c1-3-14-21-15-16(12-8-4-5-9-13(12)20-17(15)18)22(14)11-7-6-10-19-25(2,23)24/h4-5,8-9,19H,3,6-7,10-11H2,1-2H3,(H2,18,20)
InChI KeyYZOQZEXYFLXNKA-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as imidazoquinolines. These are aromatic heterocyclic compounds containing an imidazole ring fused to a quinoline ring system. In some configurations, the imidazole ring shares a nitrogen atom with the quinoline moiety.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassQuinolines and derivatives
Sub ClassImidazoquinolines
Direct ParentImidazoquinolines
Alternative Parents
Substituents
  • Imidazoquinoline
  • Aminoquinoline
  • Imidazopyridine
  • Imidazo-[4,5-c]pyridine
  • Aminopyridine
  • N-substituted imidazole
  • Pyridine
  • Organic sulfonic acid amide
  • Imidolactam
  • Benzenoid
  • Organosulfonic acid amide
  • Azole
  • Imidazole
  • Heteroaromatic compound
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Aminosulfonyl compound
  • Sulfonyl
  • Azacycle
  • Organosulfur compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Primary amine
  • Organic oxygen compound
  • Amine
  • Organic nitrogen compound
  • Organic oxide
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.82ALOGPS
logP1.32ChemAxon
logS-3.3ALOGPS
pKa (Strongest Acidic)12.07ChemAxon
pKa (Strongest Basic)5.33ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area102.9 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity98.37 m³·mol⁻¹ChemAxon
Polarizability39.46 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+178.1430932474
DeepCCS[M-H]-175.78230932474
DeepCCS[M-2H]-209.82530932474
DeepCCS[M+Na]+185.27930932474
AllCCS[M+H]+185.032859911
AllCCS[M+H-H2O]+182.232859911
AllCCS[M+NH4]+187.532859911
AllCCS[M+Na]+188.232859911
AllCCS[M-H]-183.532859911
AllCCS[M+Na-2H]-183.732859911
AllCCS[M+HCOO]-184.132859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamideCCC1=NC2=C(N1CCCCNS(C)(=O)=O)C1=CC=CC=C1N=C2N5193.1Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamideCCC1=NC2=C(N1CCCCNS(C)(=O)=O)C1=CC=CC=C1N=C2N3434.6Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamideCCC1=NC2=C(N1CCCCNS(C)(=O)=O)C1=CC=CC=C1N=C2N3510.1Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TMS,isomer #1CCC1=NC2=C(N[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3401.9Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TMS,isomer #1CCC1=NC2=C(N[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3263.3Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TMS,isomer #1CCC1=NC2=C(N[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O5155.5Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TMS,isomer #2CCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O3392.7Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TMS,isomer #2CCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O3218.4Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TMS,isomer #2CCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O5260.3Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3299.8Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3472.2Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O4621.7Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TMS,isomer #2CCC1=NC2=C(N[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O3396.4Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TMS,isomer #2CCC1=NC2=C(N[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O3387.2Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TMS,isomer #2CCC1=NC2=C(N[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O4658.2Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,3TMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O3364.4Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,3TMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O3597.2Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,3TMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C)[Si](C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C)S(C)(=O)=O4226.5Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TBDMS,isomer #1CCC1=NC2=C(N[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3572.4Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TBDMS,isomer #1CCC1=NC2=C(N[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3527.0Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TBDMS,isomer #1CCC1=NC2=C(N[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O5081.2Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TBDMS,isomer #2CCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O3588.1Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TBDMS,isomer #2CCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O3477.3Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,1TBDMS,isomer #2CCC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O5174.9Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TBDMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3629.9Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TBDMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O3965.3Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TBDMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCNS(C)(=O)=O4526.0Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TBDMS,isomer #2CCC1=NC2=C(N[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O3768.1Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TBDMS,isomer #2CCC1=NC2=C(N[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O3920.5Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,2TBDMS,isomer #2CCC1=NC2=C(N[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O4605.3Standard polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,3TBDMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O3880.8Semi standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,3TBDMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O4372.2Standard non polar33892256
N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide,3TBDMS,isomer #1CCC1=NC2=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C3C=CC=CC3=C2N1CCCCN([Si](C)(C)C(C)(C)C)S(C)(=O)=O4272.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4i-2591000000-216bb7e45db24c68a3bb2021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide 10V, Positive-QTOFsplash10-03di-1169000000-91656810853ef7819d742017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide 20V, Positive-QTOFsplash10-014i-2090000000-1eece92b3d864852eb0d2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide 40V, Positive-QTOFsplash10-03di-5290000000-195ed1edf65073ecc1242017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide 10V, Negative-QTOFsplash10-03di-4019000000-237724182748573e75022017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide 20V, Negative-QTOFsplash10-03fr-7191000000-dcdd54fd79e5a7c3915f2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide 40V, Negative-QTOFsplash10-03fu-9440000000-ed2ad1ad3239b5115b002017-07-26Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB12476
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8484580
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]